Japan Carboxy Therapy Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Table Top Devices and Portable Devices), By End-Use (Hospitals, Aesthetic Clinics, and Medspa), and Japan Carboxy Therapy Market Insights, Industry Trend, Forecasts to 2035

Japan Carboxy Therapy Market Insights Forecasts to 2035

• The Japan Carboxy Therapy Market Size Was Estimated at USD 1.69 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 13.11% from 2025 to 2035
• The Japan Carboxy Therapy Market Size is Expected to Reach USD 6.55 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Japan carboxy therapy market size is anticipated to reach USD 6.55 million by 2035, growing at a CAGR of 13.11% from 2025 to 2035. The carboxy therapy market in Japan is influenced by growing adoption of non-invasive aesthetic procedures, increasing demand for anti-aging treatment, Technological advancements, rising awareness, and availability of portable devices.

Market Overview

The Japan carboxy therapy market refers to the commercial landscape for carboxy therapy treatment, devices, and services, where carbon dioxide is used for non-surgical aesthetic and therapeutic purposes. It is primarily used for cosmetic purposes, especially skin rejuvenation and anti aging, cellulite reduction, scar/stretch-mark treatment, and to support scalp health and hair growth. Japans carboxy therapy market is growing due to higher demand for non-surgical cosmetic procedures, an aging population focused on skin care, and a preference for minimally invasive treatments. Advances in portable, automated, and safer devices are making the therapy more efficient and appealing to clinics and patients.

Key opportunities in this market refer to rising demand for non-surgical treatments, Japans aging population driving anti aging therapies, advanced devices, expanding aesthetic clinics, and untapped regional markets. In Japan, growing demand for minimally invasive cosmetic treatments is supported by government regulations and oversight through the PMDA, ensuring the safety and quality of medical devices. Initiatives promoting innovation and advanced aesthetic technologies also help drive the adoption of therapies like carboxy therapy. Government initiatives in 2024, Japan began strengthening regulatory frameworks for cosmetic and aesthetic medical treatments through amendments to medical laws, including enhanced reporting systems and inspection protocols aimed at improving safety and quality for procedures performed at clinics.

Report Coverage

This research report categorizes the market for the Japan carboxy therapy market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan carboxy therapy market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub segment of the Japan carboxy therapy market.

Driving Factors

The carboxy therapy market in Japan is expanding as more people seek cosmetic treatments, particularly non-surgical options. Demand is rising due to an aging population focused on skin health and anti aging, increasing awareness and acceptance of aesthetic procedures, and a preference for minimally invasive treatments with minimal downtime. Higher disposable incomes, growing wellness trends, and the popularity of combination therapies further support adoption. Technological innovations in  delivery devices, such as improved portability, automation, precision dosing, and safety features, have enhanced treatment effectiveness and patient comfort. Additionally, government support and streamlined regulatory approvals encourage clinic adoption, while the rising prevalence of skin conditions like cellulite and localized fat continues to drive market growth.

Restraining Factors

The carboxy therapy market in Japan faces several challenges that may slow its growth. High treatment costs, especially for multiple sessions, can limit adoption among price-conscious patients. Awareness of the therapy is still relatively low, and many people remain uncertain about its benefits. Strict medical device regulations can delay the introduction of new equipment and increase compliance costs.

Market Segmentation

The Japan carboxy therapy market share is classified into product type and end-use.

• The tabletop device segment accounted for the largest revenue market in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Japan carboxy therapy market is segmented by product type into tabletop devices and portable devices. Among these, the tabletop device segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Tabletop devices led the market due to their widespread adoption in hospitals, aesthetic clinics, and medspas. These devices support higher treatment capacity and allow clinics to serve more patients efficiently, while offering advanced features such as precise delivery, automation, and enhanced safety. Their durability, reliability, and perception as the professional standard, combined with higher unit prices, contributed to their position as the largest revenue-generating segment in the market.

• The aesthetic clinics segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 

The Japan carboxy therapy market is segmented by end-use into hospitals, aesthetic clinics, and medspas. Among these, the aesthetic clinics segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Aesthetic clinics led the market due to strong demand for non-surgical and minimally invasive cosmetic treatments. They serve patients looking for skin rejuvenation, anti-aging, and body contouring, making carboxy therapy highly relevant. Compared to hospitals and medspas, these clinics see more patients, which increases the usage of therapy devices. Their focus on specialized treatments also encourages investment in reliable and advanced  delivery equipment, reinforcing their dominant market position.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan carboxy therapy market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• DTA Medical
• Cosmo Pro Ltd
• Mezopharma
• Alvi Prague
• Carbossiterapia Italiana
• MBE Medical Divisions
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In July 2024, DTA Medical and Mezopharma launched next-generation CO₂ delivery devices featuring automated treatment protocols and enhanced safety features, which quickly gained adoption in hospital and aesthetic clinics.

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan carboxy therapy market based on the below-mentioned segments:

Japan Carboxy Therapy Market, By Product Type

• Table Top Devices
• Portable Devices

Japan Carboxy Therapy Market, By End-Use

• Hospitals
• Aesthetic clinics
• Medspa